March 9, 2018 / 5:50 PM / 7 months ago

BRIEF-Mimedx's Amniofix Injectable Granted RMAT Designation By FDA

March 9 (Reuters) - Mimedx Group Inc:

* AMNIOFIX INJECTABLE GRANTED REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION BY THE FDA FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE

* SAYS ‍FDA CONFIRMED DETERMINATION THAT MIMEDX ALLOGENEIC MICRONIZED DHACM FOR TREATMENT OF OA OF KNEE MEETS CRITERIA FOR RMAT DESIGNATION​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below